当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2018年第9期
编号:13279562
HEV vaccine in China(1)
http://www.100md.com 2018年9月1日 《特别健康·下半月》 2018年第9期
     [Abstract] Hepatitis E caused by hepatitis E virus (HEV) is one of the most common, enterically transmitted forms of viral hepatitis. At least 20 million cases of HEV are reported every year. HEV causes usually an acute, self-limited infection but frequently results in fatal disease in pregnant women and chronic infection in immunocompromised patients. Current treatment consisting of pegylated interferon and ribavirin is non-specific and has considerable side effects. A vaccine based primarily on inducing neutralizing antibodies has been developed but it is currently only licensed in China. The vaccine used a truncated ORF2 amino acid (aa) sequence of genotype (gt) 1 to neutralized gt 4 ......
1 2 3 4 5下一页

您现在查看是摘要页,全文长 2777 字符